We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$24.6B
AUM Growth
-$539M
Cap. Flow
-$2.74B
Cap. Flow %
-11.15%
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.4M
2
MSFT icon
Microsoft
MSFT
+$52.8M
3
MA icon
Mastercard
MA
+$39.5M
4
LIN icon
Linde
LIN
+$28.7M
5
RACE icon
Ferrari
RACE
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 16.99%
3 Financials 12.25%
4 Consumer Discretionary 11.39%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSGP icon
351
CoStar Group
CSGP
$12.2B
$14.8M 0.06%
247,420
-221,690
-47% -$12.9M
JCI icon
352
Johnson Controls International
JCI
$85.1B
$14.6M 0.06%
359,802
+33,191
+10% +$1.4M
BF.B icon
353
Brown-Forman Class B
BF.B
$13.5B
$14.6M 0.06%
215,312
+6,359
+3% +$413K
CMI icon
354
Cummins
CMI
$83.6B
$14.4M 0.06%
80,642
+5,110
+7% +$899K
FOLD
355
DELISTED
Amicus Therapeutics
FOLD
$14.4M 0.06%
1,478,110
+17,398
+1% +$159K
SPY icon
356
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$14.3M 0.06%
44,292
-89,929
-67% -$27.7M
P
357
Everpure Inc
P
$23B
$14.2M 0.06%
830,318
+96,065
+13% +$1.7M
IONS icon
358
Ionis Pharmaceuticals
IONS
$8.93B
$14.1M 0.06%
233,646
-30,476
-12% -$1.82M
BALL icon
359
Ball Corp
BALL
$17.5B
$14.1M 0.06%
218,130
+36,008
+20% +$2.44M
WBA
360
DELISTED
Walgreens Boots Alliance
WBA
$14.1M 0.06%
239,170
-100,866
-30% -$5.81M
PBA icon
361
Pembina Pipeline
PBA
$29.3B
$14M 0.06%
378,468
+258,050
+214% +$9.23M
DAVA icon
362
Endava
DAVA
$165M
$13.9M 0.06%
299,248
-13,379
-4% -$577K
MASI
363
DELISTED
Masimo
MASI
$13.9M 0.06%
88,088
-37,529
-30% -$5.64M
TEAM icon
364
Atlassian
TEAM
$26.5B
$13.9M 0.06%
115,382
+12,897
+13% +$1.57M
STE icon
365
Steris
STE
$22.9B
$13.9M 0.06%
91,012
+33,219
+57% +$4.87M
FANG icon
366
Diamondback Energy
FANG
$56B
$13.8M 0.06%
149,151
+3,995
+3% +$332K
XLRN
367
DELISTED
Acceleron Pharma
XLRN
$13.5M 0.06%
254,935
-111,117
-30% -$5.07M
BR icon
368
Broadridge
BR
$18.4B
$13.5M 0.05%
109,006
+4,261
+4% +$521K
CBRL icon
369
Cracker Barrel
CBRL
$1.26B
$13.4M 0.05%
87,400
-26,100
-23% -$4.11M
ABEV icon
370
Ambev
ABEV
$47.9B
$13.3M 0.05%
2,859,744
+693,838
+32% +$3.08M
ENV
371
DELISTED
ENVESTNET, INC.
ENV
$13.3M 0.05%
191,089
-65,255
-25% -$4.24M
MLNX
372
DELISTED
Mellanox Technologies, Ltd.
MLNX
$13.2M 0.05%
113,000
+17,000
+18% +$1.93M
AGIO icon
373
Agios Pharmaceuticals
AGIO
$2.08B
$13.2M 0.05%
276,952
+40,420
+17% +$1.53M
XPO icon
374
XPO
XPO
$23.4B
$13.2M 0.05%
478,095
+1,703
+0.4% +$46.8K
CTLT
375
DELISTED
CATALENT, INC.
CTLT
$13.1M 0.05%
233,037
+37,750
+19% +$1.92M

Similar funds

Axa's Q4 2019 Portfolio in Review

As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.

  • Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
  • Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
  • Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
  • Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
  • Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
  • Axa opened 97 new positions and closed 225 in Q4 2019.
  • Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.

Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.